Intimation of appointment of Chief Marketing Officer - April 22, 2025 | Download |
Intimation of Investor Meeting - March 13, 2025 | Download |
Intimation of Investor Meeting - March 05, 2025 | Download |
Intimation of Investor Meeting - March 03, 2025 | Download |
Intimation of Investor Meeting - February 21, 2025 | Download |
Intimation of Investor Meeting - February 17, 2025 | Download |
Press Release - January 23, 2025 | Download |
Monitoring Agency Report - December 31, 2024 | Download |
Intimation of Investor Meeting - December 26, 2024 | Download |
Intimation under Regulation 30 - November 29, 2024 | Download |
Intimation of Investor Meeting - November 19, 2024 | Download |
Allotment of Shares - October 16, 2024 | Download |
Monitoring Agency Report - September 30, 2024 | Download |
Intimation of Investor Meeting - September 25 -28, 2025 | Download |
Intimation of resignation of Director - September 20, 2024 | Download |
Intimation of grant of Options - August 26, 2024 | Download |
Intimation of Investor Meeting - August 26, 2024 | Download |
Intimation of Investor Meeting - August 21 to 23, 2024 | Download |
Appointment of CHRO - July 15, 2024 | Download |
Intimation of Resignation of Independent Director - July 8, 2024 | Download |
Allotment of Shares - July 07, 2024 | Download |
Monitoring Agency Report - June 30,2024 | Download |
Intimation of investor meeting - June 27 & 28, 2024 | Download |
Press Release BTPL investment - June 19, 2024 | Download |
Outcome of Board meeting - June 19, 2024 | Download |
Intimation of investor meeting - June 10 & 11, 2024 | Download |
Intimation of grant of Options - May 26, 2024 | Download |
Allotment of Shares - May 10, 2024 | Download |
ICRA Rating update - May 03, 2024 | Download |
Intimation under Regulation 30 - April 25, 2024 | Download |
Allotment of shares QIP - April 23, 2024 | Download |
Outcome of Committee meeting - April 23, 2024 | Download |
Condensed Financials – December 31, 2023 | Download |
Intimation of Investor Meeting - March 29, 2024 | Download |
Intimation of Investor Meeting - March 18, 2024 | Download |
Preferential Issue- Allotment - March 13, 2024 | Download |
Intimation of investors meeting - March 12, 2024 | Download |
Intimation of investors meeting - March 08, 2024 | Download |
Intimation of investors meeting - March 07, 2024 | Download |
Intimation of investors meeting - March 6th to March 20th, 2024 | Download |
Intimation of investors meeting - February 28, 2024 | Download |
Intimation of investors meeting - February 22 & 23, 2024 | Download |
Investor Presentation - February 13, 2024 | Download |
Rating Update ICRA - February 13, 2024 | Download |
Rating Update CRISIL - February 12, 2024 | Download |
Intimation of investors meeting IIFL Conference - February 10, 2024 | Download |
Intimation of investors meeting - Feb to March, 2024 | Download |
Intimation of acquisition of Coral - February 09, 2024 | Download |
Rating Update CRISIL Limited - January 14, 2024 | Download |
Atraco Acquisition Intimation - January 03, 2024 | Download |
Investor Meeting - December 18, 2023 | Download |
Investor Meeting - December 07, 2023 | Download |
Investor Meeting - November 29, 2023 | Download |
Investor Meeting - November 23, 2023 | Download |
Investor Meeting - November 08, 2023 | Download |
Investor Meeting - November 07, 2023 | Download |
Investor Meeting - September 21, 2023 | Download |
Investor Meeting - September 20, 2023 | Download |
Rating Update CRISIL Limited - September 06, 2023 | Download |
Investor Meeting - September 04, 2023 | Download |
Investor Meeting - September 01, 2023 | Download |
Rating Update ICRA Limited - September 06, 2023 | Download |
Intimation of investors Meeting - August 29, 2023 | Download |
Press Release - August 28, 2023 | Download |
Outcome of Board meeting - August 28, 2023 | Download |
Investors Meeting - June 29, 2023 | Download |
Investors Meeting - June 12, 2023 | Download |
Investors Meeting - June 09, 2023 | Download |
Investors Meeting - June 08, 2023 | Download |
Intimation of Postal Ballot - June 01, 2023 | Download |
Investors Meeting - May 31, 2023 | Download |
Intimation of audio link Investor Con call - May 29, 2023 | Download |
Investors Meeting - May 30, 2023 | Download |
Grant of Options - May 25, 2023 | Download |
Allotment of Shares ESOS - May 25, 2023 | Download |
Appointment of Director - April 27, 2023 | Download |
Incorporation of WOS - April 27, 2023 | Download |
Related Party Transactions - March 31, 2023 | Download |
Formation of WOS - March 31, 2023 | Download |
Investors Meeting - March 24, 2023 | Download |
Investors Meeting - March 23, 2023 | Download |
Investors Meeting - March 17, 2023 | Download |
Investors Meeting - March 10, 2023 | Download |
Investors Meeting - March 07, 2023 | Download |
Investors Meeting - March 06, 2023 | Download |
Investors Meeting - February 24, 2023 | Download |
Investors Meeting - February 23, 2023 | Download |
Investors Meeting - February 17, 2023 | Download |
Investors Meeting - February 15, 2023 | Download |
Investors Meeting - February 14, 2023 | Download |
Statement of QIP Utilization - February 14, 2023 | Download |
Appointment of Company Secretary and Compliance Officer - February 10, 2023 | Download |
Cessation of Independent Director - February 07, 2023 | Download |
Update on Subsidiary Company - January 23, 2023 | Download |
Revision in Rating - December 31, 2022 | Download |
Investors Meeting - December 28, 2022 | Download |
Investors Meeting - December 22, 2022 | Download |
Investors Meeting - December 12, 2022 | Download |
Investors Meeting - December 04, 2022 | Download |
Investors Meeting - November 29, 2022 | Download |
Cessation of term of appointment of Chairman - November 29, 2022 | Download |
Investors Meeting - November 14, 2022 | Download |
Related Party Transactions - September 30, 2022 | Download |
QIP Utilisation - October 27, 2023 | Download |
Disclosure from Promoter - October 4, 2022 | Download |
Disclosure from Promoter - October 4, 2022 | Download |
Investors Meeting - September 20, 2022 | Download |
Investors Meeting - September 19, 2022 | Download |
Investors Meeting - September 17, 2022 | Download |
Investors Meeting - September 14, 2022 | Download |
Investors Meeting - September 09, 2022 | Download |
Investors Meeting - August 24, 2022 | Download |
Investors Meeting - August 22, 2022 | Download |
RSU and ESOS allotment - August 08, 2022 | Download |
Investors Meeting - August 02, 2022 | Download |
QIP Utilisation - July 22, 2022 | Download |
Credit Rating - July 16, 2022 | Download |
Investors Meeting - June 22, 2022 | Download |
Investors Meeting - June 20, 2022 | Download |
Investors Meeting - June 16, 2022 | Download |
Investors Meeting - June 13, 2022 | Download |
Change in PSR - June 13, 2022 | Download |
Investors Meeting - May 27, 2022 | Download |
Investors Meeting - May 24, 2022 | Download |
Investors Meeting - May 23, 2022 | Download |
Investors Meeting - May 12, 2022 | Download |
Investors Meeting - May 11, 2022 | Download |
Investors Meeting - May 04, 2022 | Download |
ESOS Allotment - April 29, 2022 | Download |
RSU and ESOS allotment - April 18, 2022 | Download |
Outcome of Meeting - April 18, 2022 | Download |
RTA Name Change - April 12, 2022 | Download |
* Symbol represents mandatory fields
Mr. George Varughese is the CEO and Managing Director of Alvarez and Marsal Securities, which is the broker-dealer and investment banking unit of Alvarez and Marsal in the USA. He is based in New York.
Mr. Varughese has completed Mergers and Acquisitions, Financing and Restructuring transactions in various industries over the last 35 years. He is also the Chairman of the Opinion committee of the firm.
Before joining Alvarez and Marsal, he was partner in Merchant Banking at Credit Suisse. Previously, he was the Managing Director of DLJ Merchant Banking and established the India office for DLJ, and supervised the Asia business.
He also has served as the Professor of Finance at the Indian Institute on Management Bangalore. Currently, in addition to his duties at Alvarez and Marsal, he teaches course on Mergers and Acquisitions and Restructuring at New York University. He serves on the Board of H2 Health, a Healthcare company in the USA and is also on the Board of Vellore Foundation and Birch Family Services. He is chairman of the audit committee at H2 Health and Vellore Foundation. He also is a Member of the Investment Committee of the Fund and the co-investment program of Quilvest.
Mr. Varughese is a Bachelor in Arts from Harvard University and MBA from Stanford University.
Loading Payment Window....